EMEA-000780-PIP01-09-M06
Key facts
Invented name |
Rydapt
|
Active substance |
Midostaurin
|
Therapeutic area |
Oncology
|
Decision number |
P/0086/2021
|
PIP number |
EMEA-000780-PIP01-09-M06
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Novartis Europharm Ltd
Tel. +41 61 324 1111 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|